Relación entre la puntuación de riesgo de diabetes finlandesa y el perfil lipídico en Ecuador. Estudio de corte transversal
DOI:
https://doi.org/10.29166/rfcmq.v50i3.8420Palabras clave:
diabetes mellitus, hiperlipidemias, EcuadorResumen
Introduction: Non-communicable diseases such as type 2 diabetes mellitus and dyslipidemias are highly prevalent in Ecuador. The Finnish Diabetes Risk Score (FINDRISC) measures the 10-year risk of developing diabetes, but its relationship with lipid profile has not been studied locally. This study examined the relationship between FINDRISC test results and total, HDL, and LDL cholesterol levels in Ecuadorian primary care patients.
Objective: Analyze the relationship between the FINDRISC test score and lipid profile parameters in patients treated at primary care centers in Ecuador.
Methods: A cross-sectional study was carried out in 236 adults without diabetes. The FINDRISC test score was calculated, and clinical and biochemical data were collected. Nonparametric tests were used to analyze correlations and differences between risk groups.
Results: A moderate or higher risk of diabetes was present in 37.3% of participants. There were significant positive correlations between the FINDRISC score and both LDL (rho=0.37; p<0.001) and total cholesterol (rho=0.16; p=0.01). Intergroup differences were noted (p=0.04), but there was no correlation with HDL.
Discussion: A higher FINDRISC score is associated with increased levels of total cholesterol and LDL, suggesting the tool may be useful for identifying broader metabolic risks beyond diabetes alone. While these findings align with existing research, the study's cross-sectional design and non-probabilistic sampling limit the ability to establish causality and generalize the results to the wider population.
Conclusion: Higher LDL and total cholesterol levels are linked to increased FINDRISC scores. These findings support using the FINDRISC tool in primary care to identify broader metabolic risk
Descargas
Métricas
Citas
Institute for Health Metrics and Evaluation. Global Burden of Disease data visualizations [Internet]. 2021 [cited 2025 Jul 17]. Available from: https://vizhub.healthdata.org/gbd-compare/
Allen L, Williams J, Townsend N, Mikkelsen B, Roberts N, Foster C, et al. Socioeconomic status and non-communicable disease behavioural risk factors in low-income and lower-middle-income countries: a systematic review. Lancet Glob Health [Internet]. 2017 Mar 1 [cited 2025 Jul 17];5(3):e277–89. Available from: https://www.thelancet.com/action/showFullText?pii=S2214109X1730058X
International Diabetes Federation. IDF Diabetes Atlas 11th Edition Committee. 11th ed. 2025.
Teli M, Thato R, Rias YA. Predicting Factors of Health-Related Quality of Life Among Adults With Type 2 Diabetes: A Systematic Review. SAGE Open Nurs [Internet]. 2023 Jan 1 [cited 2025 Jul 17];9. Available from: https://scholar.google.com/scholar_url?url=https://journals.sagepub.com/doi/pdf/10.1177/23779608231185921&hl=es&sa=T&oi=ucasa&ct=ufr&ei=S955aIOZIO2rieoPmpfH4AY&scisig=AAZF9b_kHXq7Q9KUFSYWV4dh0FSr
Barcelo A, Arredondo A, Gordillo-Tobar A, Segovia J, Qiang A. The cost of diabetes in Latin America and the Caribbean in 2015: Evidence for decision and policy makers. J Glob Health [Internet]. 2017 Nov 10 [cited 2025 Jul 17];7(2):020410. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC5681710/
Berberich AJ, Hegele RA. A Modern Approach to Dyslipidemia. Endocr Rev [Internet]. 2022 Jul 13 [cited 2025 Jul 17];43(4):611–53. Available from: https://dx.doi.org/10.1210/endrev/bnab037
Pirillo A, Casula M, Olmastroni E, Norata GD, Catapano AL. Global epidemiology of dyslipidaemias. Nat Rev Cardiol [Internet]. 2021 Oct 1 [cited 2025 Jul 17];18(10):689–700. Available from: https://www.nature.com/articles/s41569-021-00541-4
Popkin BM, Adair LS, Ng SW. Global nutrition transition and the pandemic of obesity in developing countries. Nutr Rev [Internet]. 2012 Jan 1 [cited 2025 Jul 17];70(1):3–21. Available from: https://dx.doi.org/10.1111/j.1753-4887.2011.00456.x
Felix C, Lopez-Flecher M, Vega M, Andrango K, Andrango S, Parise-Vasco JM, et al. Self-Reported Prevalence of Chronic Non-Communicable Diseases Concerning Socioeconomic and Educational Factors: Analysis of the PURE-Ecuador Cohort. Glob Heart [Internet]. 2025 [cited 2025 Jul 17];20(1):29. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11908430/
Pérez-Galarza J, Baldeón L, Franco OH, Muka T, Drexhage HA, Voortman T, et al. Prevalence of overweight and metabolic syndrome, and associated sociodemographic factors among adult Ecuadorian populations: the ENSANUT-ECU study. J Endocrinol Invest [Internet]. 2021 Jan 1 [cited 2025 Jul 17];44(1):63–74. Available from: https://link.springer.com/article/10.1007/s40618-020-01267-9
Puig-García M, Caicedo-Montaño C, Márquez-Figueroa M, Chilet-Rosell E, Montalvo-Villacis G, Benazizi-Dahbi I, et al. Prevalence and gender disparities of type 2 diabetes mellitus and obesity in Esmeraldas, Ecuador: a population-based survey in a hard-to-reach setting. Int J Equity Health [Internet]. 2023 Dec 1 [cited 2025 Jul 17];22(1):1–12. Available from: https://equityhealthj.biomedcentral.com/articles/10.1186/s12939-023-01939-x
Rivadeneira J, Fuenmayor-González L, Jácome-García M, Flores-Lastra N, Delgado H, Otzen T. Impact of COVID-19 on the prevalence of dyslipidemia in Ecuador: A cross-sectional study between 2017 and 2022. Aten Primaria [Internet]. 2025 Apr 1 [cited 2025 May 21];57(4):103007. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0212656724001495
Juarez LD, Gonzalez JS, Agne AA, Kulczycki A, Pavela G, Carson AP, et al. Diabetes risk scores for Hispanics living in the United States: A systematic review. Diabetes Res Clin Pract [Internet]. 2018 Aug 1 [cited 2025 Jul 17];142:120–9. Available from: https://www.diabetesresearchclinicalpractice.com/action/showFullText?pii=S0168822717317643
Nugent R, Bertram MY, Jan S, Niessen LW, Sassi F, Jamison DT, et al. Investing in non-communicable disease prevention and management to advance the Sustainable Development Goals. The Lancet [Internet]. 2018 May 19 [cited 2025 Jul 17];391(10134):2029–35. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0140673618306676
Cheng WHG, Dong W, Tse ETY, Chan L, Wong CKH, Chin WY, et al. Recalibration of a Non-Laboratory-Based Risk Model to Estimate Pre-Diabetes/Diabetes Mellitus Risk in Primary Care in Hong Kong. J Prim Care Community Health [Internet]. 2024 Jan 1 [cited 2025 Jul 17];15. Available from: https://scholar.google.com/scholar_url?url=https://journals.sagepub.com/doi/pdf/10.1177/21501319241241188&hl=es&sa=T&oi=ucasa&ct=ufr&ei=AGV6aL6HEevO6rQPjvuDgQQ&scisig=AAZF9b9c_dRRiwTHXG08xGHa02EX
Coles B, Khunti K, Booth S, Zaccardi F, Davies MJ, Gray LJ. Prediction of type 2 diabetes risk in people with non-diabetic hyperglycaemia: model derivation and validation using UK primary care data. BMJ Open [Internet]. 2020 Oct 1 [cited 2025 Jul 17];10(10):e037937. Available from: https://bmjopen.bmj.com/content/10/10/e037937
Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD). Eur Heart J [Internet]. 2020 Jan 7 [cited 2025 Jul 17];41(2):255–323. Available from: https://dx.doi.org/10.1093/eurheartj/ehz486
Shahim B, Gyberg V, De Bacquer D, Kotseva K, De Backer G, Schnell O, et al. Undetected dysglycaemia common in primary care patients treated for hypertension and/or dyslipidaemia: On the need for a screening strategy in clinical practice. A report from EUROASPIRE IV a registry from the EuroObservational Research Programme of the European Society of Cardiology. Cardiovasc Diabetol [Internet]. 2018 Jan 24 [cited 2025 Jul 17];17(1):1–11. Available from: https://cardiab.biomedcentral.com/articles/10.1186/s12933-018-0665-4
Gagliardino JJ, Elgart JF, Bourgeois M, Etchegoyen G, Fantuzzi G, Ré M, et al. Diabetes primary prevention program: New insights from data analysis of recruitment period. Diabetes Metab Res Rev [Internet]. 2018 Jan 1 [cited 2025 Jul 17];34(1):e2943. Available from: /doi/pdf/10.1002/dmrr.2943
Poznyak A, Grechko A V., Poggio P, Myasoedova VA, Alfieri V, Orekhov AN. The Diabetes Mellitus–Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation. International Journal of Molecular Sciences 2020, Vol 21, Page 1835 [Internet]. 2020 Mar 6 [cited 2025 Jul 20];21(5):1835. Available from: https://www.mdpi.com/1422-0067/21/5/1835/htm
Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol [Internet]. 2008 Apr 1 [cited 2022 Dec 27];61(4):344–9. Available from: http://www.jclinepi.com/article/S0895435607004362/fulltext
Helsinki Statement. WMA Declaration of Helsinki – Ethical Principles for Medical Research Involving Human Subjects [Internet]. 64th WMA General Assembly. Fortaleza, Brazil; 2013 Oct [cited 2022 Dec 15]. Available from: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/
Hashemi Madani N, Ismail-Beigi F, Poustchi H, Nalini M, Sepanlou SG, Malek M, et al. Impaired fasting glucose and major adverse cardiovascular events by hypertension and dyslipidemia status: The Golestan cohort study. BMC Cardiovasc Disord [Internet]. 2020 Mar 5 [cited 2025 Jul 17];20(1):1–11. Available from: https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-020-01390-8
Nieto-Martinez R, Barengo NC, Restrepo M, Grinspan A, Assefi A, Mechanick JI. Large scale application of the Finnish diabetes risk score in Latin American and Caribbean populations: a descriptive study. Front Endocrinol (Lausanne) [Internet]. 2023 Jun 26 [cited 2025 Jul 17];14:1188784. Available from: www.unrecordporlasalud.com
Elgart JF, Torrieri R, Ré M, Salazar M, Espeche W, Angelini JM, et al. Prediabetes is more than a pre-disease: additional evidences supporting the importance of its early diagnosis and appropriate treatment. Endocrine [Internet]. 2023 Jan 1 [cited 2025 Jul 17];79(1):80–5. Available from: https://link.springer.com/article/10.1007/s12020-022-03249-8
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2025 Luis Fuenmayor
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
